CAR-T Cells Can Increase Clinical Remission Rates in Multiple Myeloma Patients – AJMC.com Managed Markets Network
|
CAR–T Cells Can Increase Clinical Remission Rates in Multiple Myeloma Patients
AJMC.com Managed Markets Network Disease progression was only found in 1 patient in the very good partial response category. However, 85% of the patients who received CAR–T cell therapy experienced cytokine release syndrome (CRS). Most of those who experienced CRS only faced mild … |
